Drug intelligence / Profile preview

Eugenia uniflora L. leaf extract

Development stage
Preclinical
Lead developer
Federal University of São Paulo
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Eugenia uniflora L. leaf extract (EEu), derived from the leaves of the pitangueira tree native to Brazil, is a botanical extract under preclinical investigation for its neuroprotective, antioxidant, and anti-inflammatory properties. Phytochemical characterization of the extract has identified several bioactive compounds, including myricetrin, oleanolic acid, pygenic acids A and B, quinic acid, galloyl-HHDP-glucose, and lauric acid. In silico target fishing and in vitro assays suggest that these bioactives interact with key Parkinson's disease-related targets, such as caspase-3 (CASP3), monoamine oxidase B (MAOB), cAMP-dependent protein kinase catalytic subunit alpha (PRKACA), and Janus kinase 3 (JAK3). Preclinical studies demonstrate that the extract exerts multifactorial neuroprotective effects by direct antioxidant action, modulating inflammatory responses, and preserving cell viability under neurotoxic conditions, making it a promising candidate for central nervous system disorders like Parkinson's disease.

Other names
EEuEugenia uniflora leaf extractpitangueira leaf extractpitangueira leaves extract
02

Targets

CASP3 (Caspase-3)JAK3 (Janus kinase 3)MAOB (Monoamine oxidase B)PKA (Cyclic amp-dependent protein kinase)

Beyond the preview

Go deeper on Eugenia uniflora L. leaf extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eugenia uniflora L. leaf extract.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call